Use of cerebrosid-kinin in preparation of medicine for preventing and treating peripheral nerve disease

A technology for peripheral nerve and peripheral nerve injury, which is applied in the field of medicine and can solve the problems that there are no reports on the prevention and treatment of peripheral nerve diseases by cerebroside and carnosine.
CN1762486AInactive Publication Date: 2006-04-26诺氏制药(吉林)有限公司

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
诺氏制药(吉林)有限公司
Publication Date
2006-04-26
Estimated Expiration
Not applicable · inactive patent
Patent Text Reader

Abstract

Disclosed is the novel use of glycoside and ignotin in the preparation of medicaments for treating diseases of peripheral nerves, wherein the glycoside and ignotin comprises active compounds such as polypeptides and ganglioside. The cattle encephalon glycoside and ignotin can be mixed with medically acceptable auxiliary materials to obtain medicinal composition in the dosage forms of tablets, capsules, granules, drop pills, injections and eye drops.
Need to check novelty before this filing date? Find Prior Art

Description

【Technical field】

[0001] The invention relates to the field of medicine, in particular to a new application of cerebroside and carnosine, and more specifically to the application of cerebroside and carnosine in the preparation of drugs for preventing and treating peripheral nerve diseases. 【Background technique】

[0002] Cerebroside and carnosine injection, such as the one produced by Northeast Pharmaceuticals (Jilin) ​​Co., Ltd. (National Drug Approval H22025046), contains active peptides and various active ingredients such as gangliosides. It has been clinically proven that it can promote brain tissue Metabolism, participate in the growth, differentiation and regeneration of brain tissue neurons, improve cerebral blood circulation and brain metabolic function, can be used to treat dysfunction caused by brain diseases, and can be used to treat dementia, traumatic brain injury, cerebral edema and other diseases; It is also used for the treatment of senile dementia, cerebrova...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More